Price
Target price
€0.82
€0.82
4.770%
0.0375
4.770%
€13.19
28.11.25 / Stuttgart Stock Exchange
WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Kala Pharmaceuticals Inc. Stock
A very strong showing by Kala Pharmaceuticals Inc. today, with an increase of €0.038 (4.770%) compared to yesterday's price.
We see a rather positive sentiment for Kala Pharmaceuticals Inc. with 12 Buy predictions and 1 Sell predictions.
With a target price of 13 € there is potential for a 1478.63% increase which would mean more than doubling the current price of 0.82 € for Kala Pharmaceuticals Inc..
Our community identified positive and negative aspects for Kala Pharmaceuticals Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the Kala Pharmaceuticals Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 4.770% | 57.457% | 24.490% | -86.229% | -87.213% | -83.947% | -99.734% |
| Ardelyx Inc. | -3.210% | 7.699% | 1.483% | -6.465% | 1.994% | 207.319% | 0.957% |
| Krystal Biotech | 0.480% | 2.688% | 15.799% | 1.421% | 24.244% | 148.816% | - |
| Evolus Inc | 1.710% | 7.207% | 4.386% | -54.231% | -43.333% | -11.194% | 93.056% |
Comments
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at HC Wainwright from $12.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $15.00 to $33.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat